Berberine inhibits WEHI-3 leukemia cells in vivo

In Vivo

Volumn 21, Issue 2, 2007, Pages 407-412

  Yu, Fu Shun ^a   Yang, Jai Sing ^a   Lin, Hui Ju ^a,b   Yu, Chun Shu ^a   Tan, Tzu Wei ^a   Lin, Yuh Tzy ^c   Lin, Chin Chung ^d,e   Lu, Hsu Feng ^f   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

^c JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^d FENG YUAN HOSPITAL   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

^f CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

Apoptosis; BALB c mice; Berberine; Cytotoxicity; WEHI 3 leukemia cells

Indexed keywords

BERBERINE; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CELL PROTEIN; PROTEIN MAC 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; GRANULOCYTE PRECURSOR; HISTOPATHOLOGY; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL; LIVER WEIGHT; MACROPHAGE; MALE; MOUSE; NONHUMAN; SPLEEN WEIGHT;

EID: 34047217905     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hahn FE and Ciak J: Antibiotics, Gottliele D, Shaw PD and Cocoran JW (eds.). Springer-Verlag, New York., Vol. 3, pp. 577, 1975.
2. Ghosh AK, Bhaktachoryya, F K and Ghosh DK: Amastigote inhibition and mode of action of berberine. Exp Parasitol 60: 404-413, 1985.
3. Hano K: Pharmacological studies on metabolism of cancer tissues: pharmacological studies on carcinostatic effects of some plant components and their derivatives (1). Gann 48: 443-450, 1957.
4. Hoshi A, Ikekawa T, Ikeda Y, Shirakawa S, Ligo M, Karetani K and Fukoka F: Antitumor activity of berberrubine derivatives. Gann 67: 321-325, 1976.
5. Zhang RX: Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Chinese Med J 103: 658-665, 1990.
6. Li KK, Motwani M, Tong W, Bornmann W and Schwartz GK: Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol 58: 1287-1293, 2000.
7. Yamagish H: Interaction between nuclei acid and berberine sulfate. J Cell Biol 15: 589-592, 1962.
8. Klimek M and Hnilica L: Ultraviolet and visible light absorption of berberine. Arch Biochem Biophys 81: 105-110, 1959.
9. Kuo CL, Chou CC and Yung BYM: Berberine complexes with DNA in berberine-induced apoptosis in human leukemia HL-60 cells. Cancer Lett 93: 193-200, 1995.
10. Yang IW, Chou CC and Yung BY: Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells. Naunyn Schmiedebergs Arch Pharmacol 354: 102-108, 1996.
11. Lin JP, Yang JS, Lee JH, Hsieh WT and Chung JG: Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 12(1): 21-28, 2006.
12. Lin CC, Lin SY, Chung JG, Lin JP, Chen GW and Kao ST: Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle. Anticancer Res 26(2A): 1097-1104, 2006.
13. Lin CC, Kao ST, Chen GW, Ho HC and Chung JG: Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 26(1A): 227-242, 2006.
14. Lin CC, Kao ST, Chen GW and Chung JG: Berberine decreased N-acetylation of 2-aminofluorene through inhibition of N-acetyltransferase gene expression in human leukemia HL-60 cells. Anticancer Res 25(6B): 4149-4155, 2005.
15. Lin CC, Kao ST, Chen GW and Chung JG: Effects of oral administration of berberine on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats. In Vivo 21: 321-328, 2007.
16. Yang JS, Kok LF, Lin YH, Kuo TC, Yang JL, Lin CC, Chen GW, Huang WW, Ho HC and Chung JG: Diallyl disulfide inhibits WEHI-3 leukemia cells in vivo. Anticancer Res 26(1A): 219-225, 2006.
17. Lu HF, Liu JY, Hsueh SC, Yang YY, Yang JS, Tan TW, Kok LF, Lu CC, Lan SH, Wu SY, Liao SS, Ip SW and Chung JG: Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo. In Vivo 21: 285-290, 2007.
18. He Q and Na XD: The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cells in vitro and in vivo. Leukemia Res 25: 455-461, 2001.
19. Taghian AG and Suitt HD: Animal systems for translational research in radiation oncology. Acta Oncol 38: 829-838, 1999.
20. Zips A, Thames HD and Baumann M: New anticancer agents: in vitro and in vivo evaluation. In Vivo 19: 1-8, 2005.
21. Gamba-Vitalo C, Blair OC, Keys SR and Sartorelui AC: Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid aclacinomycin A. Cancer Res 46: 1189-1194, 1986.
22. Burgess AW and Metcalf D: Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemia cells. Intl J Cancer 26: 647-654, 1980.
23. Metcalf D: Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia 3: 349-354, 1989.
24. Li JM and Sartorelli AC: Synergistic induction of the differentiation of WEHI-3B D+ myelomonocytic leukemia cells by retinoic acid and granulocyte colony-stimulating factor. Leukemia Res 16: 571-576, 1992.
25. Li JM, Finch RA and Sartorelli AC: Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid. Exp Cell Res 249: 279-290, 1999.